Indication
Heart Transplant Infection
4 clinical trials
6 products
1 drug
Clinical trial
Evaluation of the Tolerability and Clinical Effectiveness of Letermovir in Heart TransplantationStatus: Active (not recruiting), Estimated PCD: 2025-10-30
Product
LetermovirClinical trial
Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart TransplantationStatus: Active (not recruiting), Estimated PCD: 2023-04-17
Product
EverolimusProduct
TacrolimusProduct
Mycophenolate MofetilClinical trial
Levothyroxine Supplementation for Heart Transplant Recipients: A Randomized Control TrialStatus: Recruiting, Estimated PCD: 2027-03-01
Product
LevothyroxineDrug
VarlilumabClinical trial
Pilot Study for the Use of Shortened Preemptive Therapy With Glecaprevir/Pibrentasvir (G/P) and Ezetimibe in Hepatitis C Seronegative Solid Organ Transplant Recipients (Kidney, Heart, Lung and/or Pancreas) of Hepatitis C Viremic DonorsStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Mavyret